相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Isotope dilution LC-orbitrap-HRMS with automated sample preparation for the simultaneous quantification of 11 antimycotics in human serum
Carina Schuster et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2019)
Evaluation of a commercial liquid-chromatography high-resolution mass-spectrometry method for the determination of hepcidin-25
Dietmar Enko et al.
BIOCHEMIA MEDICA (2019)
Experience with therapeutic drug monitoring of three antifungal agents using an LC-MS/MS method in routine clinical practice
Sun Joo Yoon et al.
CLINICAL BIOCHEMISTRY (2019)
The right blood collection tube for therapeutic drug monitoring and toxicology screening procedures: Standard tubes, gel or mechanical separator?
Aurelien Schrapp et al.
CLINICA CHIMICA ACTA (2019)
Isavuconazole for treatment of rare invasive fungal diseases
Oliver A. Cornely et al.
MYCOSES (2018)
Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species
Francisco M. Marty et al.
MYCOSES (2018)
Validation of an Isavuconazole High-Performance Liquid Chromatography Assay in Plasma for Routine Therapeutic Drug Monitoring Applications
Silke C. Mueller et al.
THERAPEUTIC DRUG MONITORING (2018)
Reliable and Easy-To-Use Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Analysis of Fluconazole, Isavuconazole, Itraconazole, Hydroxy-Itraconazole, Posaconazole, and Voriconazole in Human Plasma and Serum
Carsten Mueller et al.
THERAPEUTIC DRUG MONITORING (2017)
Development and validation of a liquid chromatography-tandem mass spectrometry assay for the simultaneous quantitation of 5 azole antifungals and 1 active metabolite
Adam J. McShane et al.
CLINICA CHIMICA ACTA (2017)
Recent advances in liquid and gas chromatography methodology for extending coverage of the metabolome
Jennifer Haggarty et al.
CURRENT OPINION IN BIOTECHNOLOGY (2017)
Population Pharmacokinetics of Isavuconazole from Phase 1 and Phase 3 (SECURE) Trials in Adults and Target Attainment in Patients with Invasive Infections Due to Aspergillus and Other Filamentous Fungi
Amit Desai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial
Johan A. Maertens et al.
LANCET (2016)
Serially coupling hydrophobic interaction and reversed-phase chromatography with simultaneous gradients provides greater coverage of the metabolome
Jennifer Haggarty et al.
METABOLOMICS (2015)
LC-MS/MS in the routine clinical laboratory: has its time come?
Kelvin Sze-Yin Leung et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2014)
Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology
H. Ruth Ashbee et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Evaluation of the pharmacokinetics and clinical utility of isavuconazole for treatment of invasive fungal infections
Joanne Livermore et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2012)
Screening ionisation and chromatography conditions for quantitative LC/MS methods
Henrik Sillen et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2009)
Serial coupling of reversed-phase and hydrophilic interaction liquid chromatography to broaden the elution window for the analysis of pharmaceutical compounds
Stefan Louw et al.
JOURNAL OF CHROMATOGRAPHY A (2008)
Reference values for plasma concentrations of asymmetrical dimethylarginine (ADMA) and other arginine metabolites in men after validation of a chromatographic method
Andreas Meinitzer et al.
CLINICA CHIMICA ACTA (2007)
Harmonized guidelines for single-laboratory validation of methods of analysis - (IUPAC technical report)
M Thompson et al.
PURE AND APPLIED CHEMISTRY (2002)
Suitability of collection tubes with separator gels for collecting and storing blood samples for therapeutic drug monitoring (TDM)
J Karppi et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2000)
Comparative LC-MS and HPLC analyses of selected antiepileptics and beta-blocking drugs
ME Abdel-Hamid
FARMACO (2000)